Abstract
The overall objective of the guideline is to provide up‐to‐date, evidence‐based recommendations for the safe and effective use of oral ciclosporin in the field of dermatology. The document aims to:
offer an appraisal of all relevant literature since 1970 focusing on any key developments
address important, practical clinical questions relating to the primary guideline objective
provide guideline recommendations and, where appropriate, with some health economic implications
discuss potential developments and future directions
The guideline is presented as a detailed review with highlighted recommendations for practical use in the clinic (see section 14), in addition to an updated Patient Information Leaflet (PIL; available on the BAD website, www.bad.org.uk/leaflets).
This article is protected by copyright. All rights reserved.
http://bit.ly/2AQU0mu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου